<DOC>
	<DOC>NCT00936754</DOC>
	<brief_summary>The primary endpoint of this trial will be to evaluate the safety of a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a test meal. The secondary endpoint of this trial will be to evaluate if a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder is able to reduce the rate of carbohydrate absorption as measured by following postprandial glycemia and insulinemia.</brief_summary>
	<brief_title>Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human</brief_title>
	<detailed_description />
	<criteria>Healthy volunteer BMI between 20 and 30 Nonsmoking Iodine allergy Diabetes Use of dietary supplements for duration of study History of major surgeries or surgeries of the stomach or digestive tract</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Glycemic index</keyword>
	<keyword>Reduction of glycemic index of ingested foods</keyword>
</DOC>